Sphera Funds Management’s Cartesian Therapeutics RNAC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-25,070	Closed	-$677K	–	136
2024 Q2	$677K	Buy	25,070 +24,234	+2,899%	+$578K	0.11%	108
2024 Q1	$489K	Sell	836 -24,235	-97%	-$514K	0.08%	100
2023 Q4	$519K	Hold	25,071	–	–	0.1%	89
2023 Q3	$797K	Sell	25,071 -42,879	-63%	-$1.43M	0.19%	77
2023 Q2	$2.28M	Sell	67,950 -9,550	-12%	-$342K	0.49%	68
2023 Q1	$3.23M	Buy	+77,500	New	+$3.64M	0.7%	56
2018 Q1	–	Sell	-7,618	Closed	-$2.24M	–	137
2017 Q4	$2.24M	Hold	7,618	–	–	0.36%	88
2017 Q3	$4.17M	Hold	7,618	–	–	0.75%	46
2017 Q2	$4.54M	Hold	7,618	–	–	0.92%	34
2017 Q1	$3.27M	Sell	7,618 -1,333	-15%	-$561K	0.84%	46
2016 Q4	$4.61M	Sell	8,951 -537	-6%	-$314K	1.42%	18
2016 Q3	$3.99M	Buy	+9,488	New	+$3.71M	0.92%	36